Oxfordshire Clinical Commissioning Group
Formulary
 
back
10 Musculoskeletal and joint diseases
10-01 Osteoarthritis and soft-tissue disorders

Hyaluronic acid
Formulary

For limited use within OUHFT (NOC) as per agreed internal guidelines. 

APCO March 2009.

NB. Hyalgan® was discontinued in September 2013.


Red View adult BNF  View SPC online  View childrens BNF